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ABSTRACT: We present an artificial metalloenzyme based on the transcriptional regulator LmrR that exhibits dynamics involving
the positioning of its abiological metal cofactor. The position of the cofactor, in turn, was found to be related to the preferred
catalytic reactivity, which is either the enantioselective Friedel−Crafts alkylation of indoles with β-substituted enones or the tandem
Friedel−Crafts alkylation/enantioselective protonation of indoles with α-substituted enones. The artificial metalloenzyme could be
specialized for one of these catalytic reactions introducing a single mutation in the protein. The relation between cofactor dynamics
and activity and selectivity in catalysis has not been described for natural enzymes and, to date, appears to be particular for artificial
metalloenzymes.
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■ INTRODUCTION
Enzymes are remarkable catalysts, capable of catalyzing
chemical transformations with high rates and selectivities. A
popular approach to achieve enzymatic catalysis of reactions
that have no equivalent in nature involves the creation of
artificial metalloenzymes, which are rationally designed hybrids
of proteins with abiological catalytically active metal
cofactors.1−7 In this approach, the basal catalytic activity is
supplied by the metal complex, whereas the second
coordination sphere interactions provided by the protein
scaffold are envisioned to contribute to rate acceleration and
(enantio-)selectivity. Since the protein scaffolds used have not
naturally evolved for the reaction of interest, usually the active
site structure is far from optimal.
One key to the ability of enzymes to accelerate reactions is
their ability to provide structural complementarity of the active
site to the activated complex of the catalyzed reaction by taking
advantage of structural dynamics.8 The dynamics of the
protein involve conformational changes, e.g., domain rear-
rangement, loop motions, partial folding/unfolding, etc.,
crucial to reach the optimal structure of the active site.
Those flexible regions are also frequently involved in the
emergence of alternative active site structures and relate to
promiscuous catalytic activities. Thus, they are important
targets for mutagenesis in the natural- or directed evolution of
enzymes, including artificial metalloenzymes, to improve the
activity.9−18
A special subset of structural dynamics involves the
dynamics in binding of a metal cofactor, that is, the
interchange of cofactor position between multiple cofactor
binding sites. This is uncommon in natural enzymes as these
usually employ highly evolved cofactor binding sites. However,
artificial metalloenzymes are more rudimentary and have not
evolved for binding abiological cofactors. Hence, it is possible
that the cofactor can bind at multiple sites, that all contribute
to the overall catalysis results depending on their relative
abundance and their activity in catalysis. For example, in
artificial metalloenzymes created by dative binding of rhodium
complexes to apo carbonic anhydrase, the rhodium centers
were found to bind at multiple sites in the protein in addition
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to the primary metal binding site.19−21 Moreover, cofactor
binding dynamics has been shown to be of key importance in
the DNA equivalent of artificial metalloenzymes.22 We have
reported in supramolecular DNA-based catalysis that metal
complexes such as copper bipyridine bind reversibly at many
different locations in the DNA, resulting in many actives sites
with differently structured microenvironments in which
catalysis occurs with different activity and selectivity.23 As a
result, the overall result of catalysis is the weighted average of
the contribution of all these individual sites.24
Here, we report that dynamics in the binding position of an
abiological metal cofactor in an artificial metalloenzyme leads
to alternative active site structures in the same protein. We also
show how the activity and enantioselectivity of this artificial
metalloenzyme in two related reactions is dependent on the
position of the metal cofactor in the protein scaffold. Finally,
by a single mutation the artificial metalloenzyme can be
specialized toward either of these two catalytic reactions.
■ RESULTS AND DISCUSSION
ARM Assembly and Structure. The design of the artificial
metalloenzyme is based on the transcription factor Lactococcal
multidrug resistance Regulator (LmrR), which is a homodi-
meric protein with a size of 13.5 kDa per monomer that
contains an unusually large hydrophobic pore at the dimer
interface.25 This hydrophobic pore serves as a promiscuous
binding pocket where planar aromatic molecules bind, as
shown in X-ray and NMR structures of LmrR with various
planar drugs bound.25−27 Two tryptophan residues, one from
each subunit, i.e., W96 and W96′, play a key role in binding by
sandwiching the guest molecule via π-stacking interactions.
Previously, we have shown that this arrangement is attractive
for the supramolecular self-assembly of a novel artificial
metalloenzyme, by combining LmrR with a Cu(II) complex
with a planar aromatic ligand, like 1,10-phenanthroline (phen;
Figure 1a).28,29 LmrR showed a moderately strong affinity for
Cu(II)-phen, with a dissociation constant (Kd) of 2.6 ± 2 μM.
The importance of the central tryptophans for binding Cu(II)-
phen is illustrated by the fact that in case of the mutant
LmrR_W96A, the Kd was 1 order of magnitude lower, i.e., 45
μM.
The binding of Cu(II)-phen to LmrR was confirmed by X-
ray crystallography, which showed the phenanthroline ligand of
the complex sandwiched between W96 and W96′, with the
indole rings somewhat tilted with respect to each other and the
Cu(II) complex (Figure 1b). The Cu(II) ion is facing the front
entrance of the pore. Two carboxylate side chains, from D100
and D100′ are oriented toward the Cu(II) ion at a distance of
∼5 Å and may interact with bound ligands, e.g., water, at the
remaining coordination sites at the copper, albeit that these
could not be identified with certainty. Protein residues other
than W96 and D100 that surround the copper within a
distance of 8 Å are predominantly hydrophobic, i.e., V15, A92,
S97, V99, and I103 (and their equivalents from the dimer
mate).
Catalysis. In this study, we focused on the application of
the artificial enzymes in two catalytic reactions. First, the
previously reported enantioselective vinylogous Friedel−Crafts
alkylation of indoles with α, β unsaturated 2-acyl-imidazoles
(FC reaction), which gives rise to excellent enantioselectivities,
to up to 92% ee when catalyzed by LmrR/Cu(II)-phen (Figure
1c).28 The second reaction is the tandem Friedel−Crafts
alkylation/enantioselective protonation reaction (FC/EP re-
action, Figure 1d). It also involves the conjugate addition of
indoles to enones, but in this case the substrate carries a
methyl group at the α position and no substituent at the β
position. Hence, the chirality is introduced not in the
conjugate addition step, but in the subsequent protonation
step. This reaction represents an enantioselective protonation
in water, which is a highly challenging reaction.30 These two
reactions are mechanistically similar, but the chiral center is
created in different elementary reaction steps.24
Figure 1. (a) Schematic representation of the self-assembly of the artificial metalloenzyme. (b) Crystal structure of the LmrR/Cu(II)-phen artificial
metalloenzyme (PDB: 6R1L). Considerable disorder is observed in the binding mode of Cu-phen, as evidenced by its relatively weakly associated
electron density and high atomic B-factors. Disordered ligand binding is a general observation in crystal structures of LmrR and may be an inherent
property of this protein. Unfortunately, the weak electron density around the copper, and its special position in the crystal on a crystallographic
dyad, prohibited an unambiguous identification of its coordination geometry and ligands other than phenantroline. Close up view of the
hydrophobic pore of the LmrR. Residues used in the mutagenesis study are highlighted as sticks (color code as indicated). (c) catalyzed FC
reaction (d) catalyzed FC/EP reaction.
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The conjugate addition of 5-methoxy-1H-indole (2b) to 2-
methyl-1-(thiazol-2-yl)prop-2-en-1-one (4) was used as bench-
mark FC/EP reaction (Figure 1d, Table 1). The artificial
metalloenzyme was prepared in situ by self-assembly from 9
mol % of [Cu(phen)(NO3)2] with a slight excess (1.3 equiv)
of LmrR in MES buffer at pH 5.0. Under these conditions, the
product was obtained in 58% yield and 40% ee (entry 5).
Reducing the amount of protein to 0.67 equiv, that is, using an
excess of Cu(II)-phen, gave rise to a similar yield and ee
(Table S5, entry 2 and 4). In absence of catalyst or when using
Cu(II)-phen alone, without protein, almost no reaction was
observed (entry 1 and 2). Interestingly, using LmrR alone,
without Cu(II), gave rise to 10% yield of product with a
significant ee of 61%, albeit of the opposite enantiomer
compared to the artificial metalloenzyme (entry 3). As similar
activity in this reaction was reported recently for the regulatory
protein QacR.31 Using a combination of Cu(NO3)2 with LmrR
gave good activity, but no ee (entry 4), illustrating the
importance of the phenanthroline ligand in recruiting the
Cu(II) center to the protein. Combined these results show
that, even though protein itself has some activity in this
reaction, it is the combination of a Cu(II)-phen complex and
LmrR that is responsible for achieving good catalytic activity
and enantioselectivity. Evaluation of the indole scope showed
that the best results were obtained using 2-methyl-1H-indole
(2a), with 87% yield and 59% ee (entry 6) of product 5a.
Mutagenesis Studies. Mutagenesis of residues at various
positions in the hydrophobic pocket in spatial proximity to
W96 was performed to establish where catalysis of both these
reactions occur and which residues are important for activity.
This included positions at the front entrance, i.e., D100, F93,
and A92, residues in the pocket interior, i.e., M8, Q12, and
V99 and residues V15, E7, which are placed in the back
entrance of the pocket. Most of these residues were probed by
converting them to alanine (alanine scanning), except at
position A92 were alanine was already present. In this case
mutation to glutamate, A92E was performed.
All mutants were evaluated in both the FC reaction of 2-
methyl-indole (2a) with (E)-1-(1-methyl-1H-imidazol-2-yl)-
but-2-en-1-one (1) and the tandem FC/EP reaction of 2a with
2-methyl-1-(thiazol-2-yl)prop-2-en-1-one (4).
In the FC reaction significant effects on catalysis were
observed in case of the front entrance mutants and the mutant
M8A, which is located inside the pore (Figure 2 and Table S6).
These results confirm that the reaction occurs in the pore, at
the front entrance, close to the tryptophan residues where the
Cu(II)-phen complex is bound. In most cases, the effect of the
mutation was negative on both activity and enantioselectivity.
Table 1. Results of the Tandem Friedel-Crafts/Enantioselective Protonation (FC/EP Reaction) of Indoles with 4a
entry indole product catalyst (μM) yield of 5 (%) ee (%)b
1 2b 5b Cu(NO3)2 <5
2 2b 5b Cu(II)-phen <5
3 2b 5b LmrR 10 ± 1 61 ± 2
4 2b 5b Cu(NO3)2 + LmrR 86 ± 10 <5
5 2b 5b Cu(II)-phen + LmrR 58 ± 12 −40 ± 2
6 2a 5a Cu(II)-phen + LmrR 87 ± 14 59 ± 3
aTypical reaction conditions: 4 (1 mM), 2a/b (1 mM) in 20 mM MES buffer (pH 5.0), 150 mM NaCl, at 4 °C for 72h; results are the average of
at least two independent experiments, both carried out in duplicate. Error margins represent standard deviations. bdetermined by hplc; + and−signs
indicate which is the major enantiomer peak based on order of elution, first and second, respectively.
Figure 2. (a) Effect of mutations in LmrR on the ee of the catalyzed FC reaction between 1 and 2a and FC/EP reaction between 4 and 2a. Colors
represent the difference between the ΔΔG‡ values calculated from the corresponding ee’s as defined in panel b; (b) visualization of the mutated
residues, and the effects on enantioselectivity, onto the crystal structure of LmrR/Cu(II)-phen (metal complex omitted for clarity). The effect of
the mutation on the ee, compared to the wild-type LmrR, is visualized as a heatmap where the colors represent the difference between the ΔΔG‡
values calculated from the corresponding ee’s (ΔΔΔG‡ = ΔΔG‡mutant − ΔΔG‡wildtype), indicating an increase (blue) or decrease (red) of
enantioselectivity of the reaction catalyzed by the mutant compared to the wild type LmrR.
ACS Catalysis pubs.acs.org/acscatalysis Research Article
https://dx.doi.org/10.1021/acscatal.0c01619
ACS Catal. 2020, 10, 11783−11790
11785
Two mutations gave rise to significantly improved enantiose-
lectivity: the mutation M8A resulted in a strong increase in the
ee to 99% (Table S6, entry 11) and A92E gave rise to both
complete enantioselectivity (>99% ee) and a significantly
increased product yield (Table S6, entry 6). As reported
before, the W96A mutation caused a significant decrease in
both yield and ee (Table S6, entry 2)
In contrast, almost all of these mutations had only a small
effect on the results of the FC/EP reaction (Figure 2, Table
S7). The W96A mutation caused a decrease in the yield, but
surprisingly the ee remained similar or was even slightly higher
(Table S7, entry 3). The only mutations that gave rise to a
significant, negative, effect proved to be Q12E (Table S7, entry
10) and A92E (Table S7, entry 7). For the latter a decrease of
the ee to 21% was obtained, which was unexpected since this
same mutation proved to be the most beneficial for the FC
reaction (vide supra). Reducing the amount of protein while
keeping the Cu(II)-phen concentration the same caused a
small increase of the ee to 32% (Table S5, entry 6).
Effect of Inhibitors. The role of the hydrophobic pocket in
catalysis was probed by inhibition studies using Hoechst
H33342, which has been shown to bind with nanomolar
affinity in the pocket, sandwiched between W96 and W96′,
analogous to binding of Cu(II)-phen as observed by X-ray
crystallography.25
Fluorescence titration experiments show that H33342 can
indeed displace the Cu(II)-phen from the pore of LmrR, albeit
that more than 1 equiv is needed (SI, section V). Interestingly,
in the presence of both Cu(II)-Phen and substrate 1 or 4,
resulting in the formation of the substrate bound complexes
Cu(II)-phen -1 and Cu(II)-phen-4, more equivalents of the
Hoechst dye are required. This shows that both the substrate 1
and substrate 4 bound Cu(II) complexes do bind in the pocket
and that this binding is stronger than that of Cu(II)-phen
alone (SI, section V). These experiments show that H33342
may act as an inhibitor for catalysis, by displacing Cu(II)-phen
or Cu(II)-phen-substrate complexes from their binding site. In
view of the fact that both reactions are protein accelerated, this
should have an effect on the results of catalysis. Indeed,
addition of increasing amounts of H33342 up to 4 equiv with
respect to Cu(II)-phen caused a significant decrease in the
enantioselectivity in the FC reaction, to 57% ee (Table 2, entry
2). In case of the FC/EP reaction, after 16 h a lower yield was
observed in the presence of 4 eq of H33342 compared to
without, as expected. However, the ee was found to be higher
in the presence of H33342 (Table 2, entries 3 and 4). After 72
h, the ee of the reaction in the presence of inhibitor decreased
somewhat, which could suggest that H33342 causes
racemization, albeit very slowly (Table 2).
Competition Experiments. Next, competition experi-
ments were performed with the substrates 1 and 4, using wild
type LmrR and the mutants LmrR_W96A and LmrR_A92E
(Figures 3 and S10). When 2-methylindole (2a) was combined
with equimolar amounts of 1 and 4, the corresponding
products 3a and 5a were obtained in 66% and 17% yield,
respectively, in the reaction catalyzed by LmrR/Cu(II)-phen,
which corresponds to a selectivity of 80% for the FC reaction.
The enantioselectivity of the products was similar to that
obtained in the independent experiments. Notably, when we
carried out these competition experiments with the LmrR
variant A92E, the selectivity for the FC reaction increased to
96%; product 3a was obtained in 66% yield and 98% ee, while
only trace amounts of nearly racemic product 5a were
obtained. In contrast, when we used the mutant LmrR_W96A,
the FC/EP reaction became the dominant activity, with a
selectivity of 76%; product 5a was obtained with 22% yield and
69% ee. These results show how with one single mutation,
either one of these catalyzed reactions can be made the
dominant activity of the artificial metalloenzyme.
Effect of A92 Mutation. While the effect of the W96A
mutation is clear, that is, it eliminates a crucial part of the
Cu(II)-phen binding site, the role of the glutamate residue in
the A92E mutant was less obvious. The binding affinity of the
[Cu(phen)(NO3)2] was determined (SI, Section VIII) and a
dissociation constant (Kd) of 65 ± 19 nM and 59 ± 16 nM was
found at pH 7 and 5, respectively. This represents a 2 orders of
magnitude increase in binding affinity compared to WT LmrR
(Table S9). Our initial hypothesis was that the carboxylate
moieties would contribute to binding of the copper complex by
interaction with the Cu(II) ion. For this reason, the
corresponding glutamine mutant (i.e., A92Q) was prepared,
since glutamine is sterically similar to glutamate, but is not a
good ligand for Cu(II). However, the A92Q mutant also
showed an increased affinity for Cu(II)-phen (Kd 103 ± 41
nM; Figure S12), albeit that the results in catalysis were similar
to the wild-type LmrR (Tables S6, entry 7 and S7, entry 8).
The increased affinity of the A92E mutant for Cu(II)-phen also
allowed to determine the apparent catalytic efficiency of this
improved mutant for the FC reaction: kcat/KM = 73.3 M
−1
min−1 (Figure S14). This information could not be obtained
for the wild type LmrR-based artificial metalloenzyme since, in
this case, the binding affinity of the Cu(II)-phen complex to
the wild type protein is moderate. At higher concentrations
this causes the substrates to start displacing the Cu(II)-phen
complex, which leads to a significant decrease of the catalytic
activity.28 Unfortunately, due to substrate solubility issues, the
individual Michaelis Menten parameters kcat and KM could not
be determined.
Table 2. Results of the Competitive Binding of Hoechst
33342 to LmrR in the Friedel-Crafts (FC Reaction) and the






(h) product yield (%) ee (%)
1 1 0 72 3a 41 ± 12 92 ± 2
2 1 4 72 3a 29 ± 18 57 ± 5
3b 4 0 16 5a 53 ± 6 56 ± 1
4b 4 4 16 5a 38 ± 1 73 ± 1
5b 4 0 72 5a 70 ± 16 58 ± 2
6b 4 4 72 5a 60 ± 6 61 ± 1
aTypical reaction conditions: 1/4 (1 mM), 2a (1 mM), [Cu(II)-
phen] (9 mol %; 90 μM), LmrR (12 mol %; 120 μM), H33342 (0 or
4 equiv with respect to the concentration of Cu(II)-phen) in 20 mM
MOPS buffer (pH 7.0), 150 mM NaCl, at 4 °C; results are the
average of at least two independent experiments, both carried out in
duplicate. b20 mM MES buffer (pH 5.0), 150 mM NaCl.
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Computation was then used to gain a better understanding
about the effect of mutation A92E. For this purpose, the bis
aqua form of the copper bound phenanthroline cofactor
[Cu(phen)(H2O)2]
2+ was optimized via quantum calculations
and embedded into the WT, A92E and A92Q variants of LmrR
via protein−ligand docking (see details in the Supporting
Information, section X). The best scored structures showed in
all cases the copper-phenanthroline moiety at the center of the
cavity packed between tryptophans W96/W96′, a result
consistent with the X-ray structure. Those were subsequently
submitted to 300 ns MD simulation.
The MD simulations for WT LmrR showed that hydro-
phobic interactions between A92 and V15 contribute to a
somewhat closed arrangement of the active site, in which the
indole rings of W96/W96′ are slightly tilted with respect to
each other, in agreement with the X-ray structure (Figure 4,
left). Hence, the π-stacking interactions between the indole
rings of residues W96/W96′ and the phenanthroline ligand are
not optimal. Hydrogen bonding interactions between the water
ligands and residues D100/D100′ contribute to maintain the
positioning of the copper cofactor.
Instead, according to the MD simulations, the mutation of
the alanine to glutamate in the A92E mutant disrupts the
hydrophobic interaction and generates a hydrogen bonding
network at the back of the active site, involving mainly residues
N88 of helix α4 and N14, located at the opposite side of the
cavity in helix α1 (Figures S16 and S17, left). This contributes
to a different structural arrangement of the pore, with a parallel
orientation of the W96/W96′ indoles and an expanded
hydrophobic free volume of the cavity (Figures S18 and
S19). The result is a better packing of the Cu(II)-phen
complex by a dual π-stacking interaction from W96/W96′.
Tentatively, this is related to the increased binding affinity, and
causes the Cu(II)-phen being positioned deeper inside the
pore (Figure S19). While these structures are found frequently
in the A92E mutant (40% of the MD simulation), they are
virtually nonexistent in case of the WT protein (1% of the MD
simulation). Similar structures were observed for the A92Q
mutant, albeit these were less frequent than for the A92E
mutant (Supporting Information). These results suggest that
the A92E mutation does not have a direct effect on catalysis,
but mainly has a structural effect, which translates into stronger
binding of the Cu(II)-phen complex.
■ DISCUSSION
The both reactions investigated here, the Cu(II)-phen/LmrR
catalyzed FC and FC/EP reaction, are mechanistically similar,
the only difference being that in the FC reaction the
stereocenter is introduced in the conjugate addition step,
whereas in the FC/EP reaction the stereocenter is created in
the subsequent protonation of the enolate intermediate. Yet
some marked differences were observed in how these reactions
respond to mutations, addition of inhibitors and in
competition experiments.
Figure 3. (a) Competition experiment between FC reaction of 1 with 2a (and FC/EP reaction of 4 with 2a) catalyzed by LmrR/Cu(II)-phen,
LmrR_A92E/Cu(II)-phen and LmrR_W96A/Cu(II)-phen. All substrates were present in equimolar amounts (1 mM). (b) Relative product
distribution (%) of the competing FC (green) and FC/EP reactions (blue). (c) ee values for products of the FC and FC/EP reaction in the
competition experiment catalyzed by LmrR mutants with standard deviations shown.
Figure 4. Comparison between representative structures of the pore
along 300 ns of MD simulation for WT (left) and A92E (right)
variants of LmrR with Cu(II)-phen bound. For WT, hydrophobic
interactions between A92 and V15 promote closing of the active site,
resulting in a not optimal π-stacking between both W96/W96′ and
the phenanthroline ligand of the Cu(II)-phen cofactor. In contrast,
the A92E mutant enables polar interactions with N14, which
contribute to the opening of the active site and a parallel orientation
of the W96/W96′ residues and, thus, cause a better binding of the
phenanthroline ligand via π-stacking.
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The combined data suggest that the FC and FC/EP reaction
both primarily occur in the hydrophobic pocket of LmrR, with
the Cu(II)-phen catalytic complex bound between the two
central tryptophans W96 and W96′ as suggested by the
combined spectroscopy and X-ray crystallography data. This is
supported by the fact that removing the tryptophans by
mutation to alanine, or displacing the Cu(II)-phen from the
pocket by addition of Hoechst H33342 as inhibitor results in a
decrease of the yield of product in both reactions. Moreover,
the mutagenesis study clearly shows that the ee’s of the FC
reaction are most affected by mutations in the center of the
pore at the front entrance, near W96/W96′, where the Cu(II)
site is located in the X-ray structure. Notable in this regard is
the A92E mutation, which significantly increases the binding
affinity of Cu(II)-Phen: this gives rise to the highest activity
and selectivity in the FC reaction. In the case of the FC/EP
reaction, the ee’s do not show strong dependence on most of
the mutations in this location, but it should be noted that the
stereocenter is created in a different elementary step and
hence, may not be influenced by mutations in the same way.
However, some of the observations made for the FC/EP
reaction appear to conflict with the active site being located at
the front entrance of the pore and comprised of the Cu(II)-
phen bound between the W96/W96’. For example, when this
active site cannot form because Cu(II)-phen binding between
the two tryptophans is blocked, by addition of the inhibitor
Hoechst H33342, or by removal of W96/W96’ by muta-
genesis, the enantioselectivity of the reaction actually increases.
Conversely, in cases where the binding of Cu(II)-phen is
favored, such as in the A92E mutant, the enantioselectivity
strongly decreases.
We propose that this apparent dichotomy can be resolved by
considering the dynamics of binding of the Cu-phen cofactor,
which is a result of the moderate binding affinity of Cu(II)-
phen for wild type LmrR. This means that under the
conditions of catalysis, most of the Cu(II)-phen is bound
between the tryptophans, which is the primary active site.
However, a non-neglible fraction of the Cu(II) complex does
not bind there and, most likely, can interact at another position
of the protein. At present, the location of this secondary active
site is unknown. It also cannot be ruled out that there is more
than one secondary site. These secondary active sites could be
at a different position in or close to the hydrophobic pore but
could also be on the surface of the protein (Figure 5). The role
of the protein is clear as the FC/EP reaction does not occur, or
only very slowly, in the absence of protein combined with the
enantioselectivity of product 5. This means that the ARM is
not one well-defined species, but a mixture of copper
complexes residing in a different protein microenvironment
and the outcome of the catalysis is the weighted average of the
contribution of these different active sites. This is highly
reminiscent of what was observed before in our work on
salmon testes DNA-based catalysis.23
In both the FC and FC/EP reaction, the primary active site
dominates the outcome of catalysis because most of the
Cu(II)-phen and the intermediates [Cu(II)-phen-1] and
[Cu(II)-phen-2] are bound here and it significantly accelerates
the reaction. This is also the reason that, when using an excess
of Cu(II)-phen compared to protein, the results of catalysis do
Figure 5. Schematic explanation of the observed metal cofactor binding dynamics of LmrR-based artificial metalloenzymes and the relation to
catalysis. Most of the Cu(II)-phen complex will bind in the cavity between the two Trp residues W96/W96′ (primary active site), where it can bind
and activate the substrate to undergo conjugate addition by an indole nucleophile, resulting in formation of the product (top pathway, “major
species”). This pathway gives rise to the highest ee’s in the FC reaction. However, a small but non-neglible fraction of the Cu(II)-phen can bind at
other positions in LmrR (secondary active sites) where it can also activate a substrate for reaction with the indole (lower pathway, “minor” species).
This is the pathway that gives the highest ee in the FC/EP reaction. Note that the position of the metal cofactor in the protein in the lower pathway
is arbitrary. At present, this secondary site/sites have not been identified.
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not decrease. In case of the FC reaction this also gives the
highest enantioselectivity. But in case of the FC/EP reaction, it
appears that the primary site is not the most enantioselective,
but the secondary site(s). Indeed by blocking or eliminating
the primary active site by removal of W96, the relative
contribution of secondary site(s) increases, resulting in a
higher ee. Conversely, by favoring the primary active site
through the A92E mutation, which strongly increases the
affinity of Cu(II)-phen for binding between W96/W96′,
basically there is/are no more secondary site(s), resulting in
a decreased enantioselectivity in the FC/EP reaction but an
increase in the FC reaction. By using an excess of Cu(II)-phen
compared to LmrR_A92E mutant, some of the secondary sites
get occupied again, which is reflected in an small increase of ee
in the case of the FC/EP reaction.
The competition experiments are in agreement with this
hypothesis. Using LmrR, both the FC and FC/EP reaction are
possible, but the former is preferred in the primary active site.
Making a single mutation, A92E, results in further favoring of
reaction via the primary active site (top pathway) and the
secondary site(s) (lower pathway) is effectively shut down
(Figure 5). This is reflected in the results: the A92E mutant
strongly prefers the FC reaction over the FC/EP reaction.
Conversely, by removing the central tryptophans via the W96A
mutation only the lower pathway can be followed, since it
eliminates the preferred primary binding site for the Cu(II)-
phen complex. The FC reaction is still possible, albeit with
lower activity and selectivity. In this case, the FC/EP reaction
is now the favored reaction, resulting in an increased yield and
enantioselectivity of the FC/EP product.
■ CONCLUSION
In conclusion, the LmrR/Cu(II)-phen artificial metalloenzyme
shows dynamic behavior in the positioning of its abiological
metal cofactor, which, in turn, is related to the activity and
selectivity in catalysis. In the WT LmrR/Cu(II)-phen, the FC
reaction, which occurs in the primary active site in the
hydrophopbic pore of the protein, is the preferred activity.
However, it exhibits lower, but significant, levels of activity for
another reaction, the FC/EP reaction, which is mechanistically
similar but involves an enantioselective protonation step.
However, the FC/EP reaction achieves the highest enantiose-
lectivity when it occurs in a secondary active site. By only one
mutation, A92E, this artificial metalloenzyme became almost
fully selective for the FC reaction, while by another mutation,
i.e., W96A, the FC/EP reaction became the dominant activity.
The switching of preferred activity and selectivity by dynamic
interconversion of the position of a metal cofactor has not
been described for natural enzymes and, to date, appears to be
particular for artificial metalloenzymes. Thus, this study
underlines the importance of cofactor binding dynamics as a
key element of artificial enzyme design.
■ ASSOCIATED CONTENT
*sı Supporting Information
The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acscatal.0c01619.
Detailed experimental procedures, characterization data
for all new compounds and proteins, additional catalysis
and biophysical data, X-ray crystallography data, details




Lara Villarino − Stratingh Institute for Chemistry, University of
Groningen, 9747, AG, Groningen, The Netherlands;
orcid.org/0000-0003-4728-2001; Email: lara.villarino@
usc.es
Gerard Roelfes − Stratingh Institute for Chemistry, University of
Groningen, 9747, AG, Groningen, The Netherlands;
orcid.org/0000-0002-0364-9564; Email: j.g.roelfes@rug.nl
Authors
Shreyans Chordia − Stratingh Institute for Chemistry,
University of Groningen, 9747, AG, Groningen, The
Netherlands
Lur Alonso-Cotchico − Stratingh Institute for Chemistry,
University of Groningen, 9747, AG, Groningen, The
Netherlands; orcid.org/0000-0002-0172-6394
Eswar Reddem − Stratingh Institute for Chemistry, University of
Groningen, 9747, AG, Groningen, The Netherlands
Zhi Zhou − Stratingh Institute for Chemistry, University of
Groningen, 9747, AG, Groningen, The Netherlands;
orcid.org/0000-0001-7926-118X
Andy Mark W. H. Thunnissen − Groningen Biomolecular
Sciences and Biotechnology Institute, University of Groningen,
9747, AG, Groningen, The Netherlands
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M.; Lebrun, V.; Reuter, R.; Köhler, V.; Lewis, J. C.; Ward, T. R.
Artificial Metalloenzymes: Reaction Scope and Optimization
Strategies. Chem. Rev. 2018, 118, 142−231.
(2) Davis, H. J.; Ward, T. R. Artificial Metalloenzymes: Challenges
and Opportunities. ACS Cent. Sci. 2019, 5, 1120−1136.
(3) Drienovska,́ I.; Roelfes, G. Artificial Metalloenzymes for
Asymmetric Catalysis by Creation of Novel Active Sites in Protein
and DNA Scaffolds. Isr. J. Chem. 2015, 55, 21−31.
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(31) Gutieŕrez de Souza, C.; Alonso-Cotchico, L.; Bersellini, M.;
Roelfes, G. Unexpected Catalytic Activity of the Regulatory Protein
QacR. 2020 DOI: 10.26434/chemrxiv.12662003.v1.
ACS Catalysis pubs.acs.org/acscatalysis Research Article
https://dx.doi.org/10.1021/acscatal.0c01619
ACS Catal. 2020, 10, 11783−11790
11790
